Zhang W Y, Gaynor P M, Kruth H S
Section of Experimental Atherosclerosis, NHLBI, National Institutes of Health, Bethesda, Maryland 20892, USA.
J Biol Chem. 1997 Dec 12;272(50):31700-6. doi: 10.1074/jbc.272.50.31700.
Aggregation of low density lipoprotein (LDL) stimulates its uptake by macrophages. We have now shown by electron microscopic and chemical experiments that aggregated LDL (produced by vortexing (VxLDL) or treatment with phospholipase C) induced and became sequestered in large amounts within surface-connected compartments (SCC) of human monocyte-derived macrophages. This occurred through a process different from phagocytosis. Formation of SCC and accumulation of aggregated LDL in SCC are cell-mediated processes that were temperature-dependent (10 x greater cell association at 37 degrees C than at 4 degrees C) and blocked by cytochalasin D but not by nocodazole. Because of the surface connections of SCC, trypsin could release aggregated LDL from SCC. Degradation of 125I-VxLDL through the SCC pathway showed delayed and a lower rate of degradation (10-55%) compared with nonaggregated 125I-acetylated LDL that did not enter SCC. However, similar to 125I-acetylated LDL degradation, 125I-VxLDL degradation occurred through a chloroquine-sensitive pathway. Uptake of VxLDL into SCC was not mediated by the LDL receptor. Methylation of LDL prevents its binding to the LDL receptor. However, methylated LDL still entered SCC after it was aggregated by vortexing. On the other hand, degradation of 125I-VxLDL was substantially decreased by methylation of LDL and by cholesterol enrichment of macrophages, which decreases macrophage LDL receptor expression. The results suggest that whereas uptake of aggregated LDL into SCC occurs independently of the LDL receptor, movement of aggregated LDL from SCC to lysosomes may depend in part on LDL receptor function. Sequestration into SCC is a novel endocytosis pathway for uptake of aggregated LDL that allows the macrophage to store large amounts of this lipoprotein before it is further processed.
低密度脂蛋白(LDL)的聚集会刺激巨噬细胞对其摄取。我们现在通过电子显微镜和化学实验表明,聚集的LDL(通过涡旋产生(VxLDL)或用磷脂酶C处理)诱导并大量隔离在人单核细胞衍生巨噬细胞的表面连接隔室(SCC)内。这一过程不同于吞噬作用。SCC的形成以及聚集的LDL在SCC中的积累是细胞介导的过程,这些过程依赖于温度(37℃时细胞结合量比4℃时大10倍),并被细胞松弛素D阻断,但不被诺考达唑阻断。由于SCC的表面连接,胰蛋白酶可以从SCC中释放聚集的LDL。与未进入SCC的非聚集125I-乙酰化LDL相比,通过SCC途径降解125I-VxLDL显示出降解延迟且降解速率较低(10-55%)。然而,与125I-乙酰化LDL降解类似,125I-VxLDL降解通过对氯喹敏感的途径发生。VxLDL进入SCC不是由LDL受体介导的。LDL的甲基化会阻止其与LDL受体结合。然而,甲基化的LDL在通过涡旋聚集后仍会进入SCC。另一方面,LDL的甲基化以及巨噬细胞胆固醇富集(这会降低巨噬细胞LDL受体表达)会使125I-VxLDL的降解大幅减少。结果表明,虽然聚集的LDL进入SCC的摄取独立于LDL受体,但聚集的LDL从SCC向溶酶体的移动可能部分依赖于LDL受体功能。隔离到SCC中是一种摄取聚集LDL的新型内吞途径,它使巨噬细胞能够在进一步处理之前储存大量这种脂蛋白。